7,562.75

+21.35

+0.28%

51,748.29

-235.69

-0.45%

25,345.30

+180.93

+0.72%

2,818.77

+12.89

+0.46%

4.9520

+0.0580

+1.19%

20.97

-0.18

-0.85%

3,929.30

-40.30

-1.02%

77,550.48

+910.73

+1.19%

Crude Oil Dec 26

96.71

+0.25

+0.26%

US Private Equity

10,836.30

-14.33

-0.13%

OTC Markets OTCPK - Delayed Quote USD

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

2.2000 +0.0250 (+1.15%)

As of October 30 at 4:00:00 PM EDT. Market Open.

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

PR Newswire 1mo ago

2196.HK

600196.SS
Fosun Pharma Announces 2026 Interim Results

PR Newswire 2mo ago
Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease

PR Newswire 5mo ago

600196.SS
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

PR Newswire 6mo ago

600196.SS
Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework

PR Newswire 6mo ago

600196.SS

2196.HK
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

PR Newswire 10mo ago

PFE

SFOSF
+1.15%

Mobilize your Website

View Site in Mobile | Classic

Share by: